References and Notes
For reviews, see:
1a
Dolbier WR.
Chem. Rev.
1996,
96:
1557
1b
Dolbier WR.
Top. Curr. Chem.
1997,
192:
97
1c
Améduri B.
Boutevin B.
Top. Curr. Chem.
1997,
192:
165
2
Organofluorine Chemistry, Principles and Commercial Applications
Banks RE.
Smart BE.
Tatlow JC.
Plenum;
New York:
1994.
3a
Lopin C.
Gautier A.
Gouhier G.
Piettre SR.
J. Am. Chem. Soc.
2002,
124:
14668 ; and references therein
3b
Okano T.
Nakajima A.
Eguchi S.
Synlett
2001,
1449
3c
Bumgardner CL.
Burgess JP.
J. Fluorine Chem.
2000,
102:
5478
3d
Herpin TF.
Motherwell WB.
Roberts BP.
Roland S.
Weibel J.-M.
Tetrahedron
1997,
53:
15085
For reports on the radical cyclization of fluoroalkenes, see:
4a
Morikawa T.
Uchida J.
Hasegawa Y.
Taguchi T.
Chem. Pharm. Bull.
1991,
39:
2462
4b
Morikawa T.
Nishiwaki T.
Iitaka Y.
Kobayashi Y.
Tetrahedron Lett.
1987,
28:
671
5
Ichikawa J.
Wada Y.
Miyazaki H.
Mori T.
Kuroki H.
Org. Lett.
2003,
5:
1455
6
Ichikawa J.
Wada Y.
Fujiwara M.
Sakoda K.
Synthesis
2002,
1917
7
Tokuyama H.
Fukuyama T.
Chem. Rec.
2002,
2:
37
8a
Beckwith ALJ.
Chem. Soc. Rev.
1993,
143 ; and references therein
8b
Curran DP.
Porter NA.
Giese B.
Stereochemistry of Free Radical Reactions
VCH;
Weinheim:
1996.
For recent reports on radical 6-endo-trig cyclizations, see:
9a
Tojino M.
Otsuka N.
Fukuyama T.
Matsubara H.
Ryu I.
J. Am. Chem. Soc.
2006,
128:
7712
9b
Ishibashi H.
Chem. Rec.
2006,
6:
23 ; and references therein
9c
Chapelon A.-S.
Ollivier C.
Santelli M.
Tetrahedron Lett.
2006,
47:
2747 ; and references therein
9d
Bennasar M.-L.
Roca T.
Ferrando F.
J. Org. Chem.
2006,
71:
1746 ; and references therein
9e
Mal SK.
Some S.
Ray JK.
Synlett
2005,
1951 ; and references therein
9f
Flisinska-Luczak J.
Lesniak S.
Nazarski RB.
Tetrahedron
2004,
60:
8181
10a
Sheffy F.
Godschalx JP.
Stille JK.
J. Am. Chem. Soc.
1984,
106:
4833
10b
Stille JK.
Groh BL.
J. Am. Chem. Soc.
1987,
109:
813
10c
Echavarren AM.
Stille JK.
J. Am. Chem. Soc.
1987,
109:
5478
11
4-Butyl-3-fluoro-2-phenylquinoline (
7c)
To a solution of 1a (113 mg, 0.51 mmol) in toluene (4 mL) was added n-Bu3SnH (0.15 mL, 0.56 mmol) and a catalytic amount of AIBN under Ar. The reaction mixture was heated at 80 °C for 1 h and removal of the solvent under reduced pressure. To a solution of the residue in DMF (3 mL) were added PhI (102 mg, 0.50 mmol), Pd(PPh3)4 (48 mg, 0.042 mmol), and CuI (40 mg, 0.21 mmol) at r.t. After the reaction mixture was stirred for 2 h at 80 °C, DBU (0.070 mL, 0.46 mmol) was added, and the reaction mixture was heated at 80 °C for 1 h. The reaction was quenched with phosphate buffer (pH 7), and the mixture was filtered through Celite®. Organic materials were extracted with Et2O three times. The combined extracts were washed with aq KF, brine, and dried over MgSO4. After removal of the solvent under reduced pressure, the residue was purified by preparative TLC on silica gel (hexane-EtOAc, 10:1) to give 7c (100 mg, 70%) as a pale yellow oil. 1H NMR (500 MHz, CDCl3): δ = 0.98 (3 H, t, J = 7.6 Hz), 1.49 (2 H, tq, J = 7.6, 7.6 Hz), 1.67-1.76 (2 H, m), 3.14 (2 H, td J = 7.6 Hz, J
HF = 1.9 Hz), 7.49-7.57 (4 H, m), 7.63-7.67 (1 H, m), 7.96 (1 H, d, J = 8.2 Hz), 8.02-8.06 (2 H, m), 8.16 (1 H, d, J = 8.2 Hz). 13C NMR (126 MHz, CDCl3): δ = 13.8, 22.8, 24.7 (d, J
CF = 4 Hz), 31.9, 123.3 (d, J
CF = 5 Hz), 126.8, 127.8 (d, J
CF = 3 Hz), 128.1, 128.4, 129.3, 129.4, 130.8, 132.6 (d, J
CF = 15 Hz), 136.2 (d, J
CF = 5 Hz), 145.2 (d, J
CF = 3 Hz), 148.6 (d, J
CF = 17 Hz), 152.9 (d, J
CF = 256 Hz). 19F NMR (471 MHz, CDCl3/C6F6): δ = 32.4 (s). IR (neat): 2958, 2929, 2871, 1603, 1458, 1406, 1381, 1362, 1192, 760 cm-1. HRMS-FAB: m/z calcd for C19H19FN: 280.1502 [M + 1]+; found: 280.1495.
For reports on the effect of alkene substitution in radical 5-exo-trig/6-endo-trig cyclizations, see:
12a
Hartung J.
Kneuer R.
Rummey C.
Bringmann G.
J. Am. Chem. Soc.
2004,
126:
12121 ; and references therein
12b
Della EW.
Graney SD.
J. Org. Chem.
2004,
69:
3824 ; and references therein
13
Kato T.
Saeki K.
Kawazoe Y.
Hakura A.
Mutat. Res.
1999,
439:
149 ; and references therein
14a
Ackermann L.
Born R.
Spatz JH.
Meyer D.
Angew. Chem. Int. Ed.
2005,
44:
7216
14b
Mongin F.
Mojovic L.
Guillamet B.
Trécourt F.
Quéguiner G.
J. Org. Chem.
2002,
67:
8991
14c
Rocca P.
Marsais F.
Godard A.
Quéguiner G.
Tetrahedron
1993,
49:
49
15
Olajide OA.
Heiss EH.
Schachner D.
Wright CW.
Vollmar AM.
Dirsch VM.
Bioorg. Med. Chem.
2007,
15:
43 ; and references therein
16
Hadden CE.
Sharaf MHM.
Guido JE.
Robins RH.
Tackie AN.
Phoebe CH.
Schiff PL.
Martin GE.
J. Nat. Prod.
1999,
62:
238
17
Arzel E.
Rocca P.
Grellier P.
Labaeïd M.
Frappier F.
Guéritte F.
Gaspard C.
Marsais F.
Godard A.
Quéguiner G.
J. Med. Chem.
2001,
44:
949
For reports on the synthesis of cryptolepine, see:
18a
Dhanabal T.
Sangeetha R.
Mohan PS.
Tetrahedron
2006,
62:
6258
18b
Onyeibor O.
Croft SL.
Dodson HI.
Feiz-Haddad M.
Kendrick H.
Millington NJ.
Parapini S.
Phillips RM.
Seville S.
Shnyder SD.
Taramelli D.
Wright CW.
J. Med. Chem.
2005,
48:
2701
18c
Ho T.-L.
Jou D.-G.
Helv. Chim. Acta
2002,
85:
3823 ; and references therein
18d
Bierer DE.
Dubenko LG.
Zhang P.
Lu Q.
Imbach PA.
Garofalo AW.
Phuan P.-W.
Fort DM.
Litvak J.
Gerber RE.
Sloan B.
Luo J.
Cooper R.
Reaven GM.
J. Med. Chem.
1998,
41:
2754